Biopharma e-Clinical trials

Optimizing drug development

Paper-based clinical trials have traditionally been hampered by costly budget overruns and serious delays in locking databases prior to regulatory submission. Intel's goal is to help drive the uptake of electronic clinical solutions that make electronic data capture, clinical trial data management, and electronic regulatory submission the norm for clinical trials.

Clinical investigators require ubiquitous access to data and information throughout their clinical setting, but relying upon paper-based records or desktop computers do not allow them to efficiently capture clinical trial data. Our extensive experience deploying tablet PCs based upon Intel® Centrino® processor technology can improve study workflow and speed the capture of clinical trial data. Intel® mobile technologies also provide advanced capabilities to enhance data security, benefiting both investigators and sponsors.

Scalable and reliable Intel® server technologies provide the building blocks for your growing e-Clinical infrastructure that can help streamline clinical trial operations and accelerate regulatory approvals. Intel based solutions improve the data center while delivering outstanding performance for even the most demanding workloads.

As e-Clinical solutions are deployed to a larger number of groups across a biopharma and its partners, such as contract research organizations and investigator sites, the need to integrate many point solutions with adjacent technologies becomes increasingly necessary. Through its participation in open standards development efforts, such as CDISC and HL7, Intel is also helping to promote data and technology interoperability and advance opportunities for integration of patient-level and clinical research information.